Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 610 participants.
Also called NCT02681016
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 610 participants
- Registry
-
NCT02681016
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT02681016. Randomized; single masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2017-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE
- Acronym
- PATRIOT
- Condition
- Ischemic Heart Disease
- Condition
- Coronary Atherosclerosis
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Stenosis
- Intervention (Device)
- DES "Calypso"
- Intervention (Device)
- DES "Xience Prime"
- Intervention (Procedure)
- Coronary angioplasty
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
Record details
- Record id
cardio:ct-nct02681016- Content hash
6d89b91c51e94ccec1439bf177b975aae00ca09f53bce5c1d724f479042799bf